Microscopic image of SCP-XXXX.
Item #: SCP-XXXX
Object Class: Keter
Special Containment Procedures: Samples of SCP-XXXX selected and subsequently approved for research purposes are to be stored in Petri Dishes within properly labeled, hermetically sealed, 1.0 m x 1.0 m x 0.5 m containers to avoid possible outbreaks and mishandling. It is imperative that these containers are only to be opened and studied at Sector-9 of Bio-Site-XXXX with proper equipment.
Locations that have been infected with SCP-XXXX must be evacuated cautiously and quarantined within a sealed, sterile tent for no less than 72 hours. This tent must cover the entirety of the structure and remain secure for 72 hours minimum. If a sterile tent is not available, then armed guards must patrol the perimeter of the building until it is considered decontaminated. If any human gets within 1 meter of the building, then it is mandated that that person must be treated as a potentially infected individual.
Individuals that have come into contact with SCP-XXXX must immediately begin wearing a surgical mask and be transported to Sector-4 of Bio-Site-XXXX for testing.
Treat all infected individuals with tact but do not engage in physical contact with them. If a person comes into contact with an infected individual, that person must be treated as a potentially infected individual and go through proper protocol.
Description: SCP-XXXX is an anomalous bacterium that is immune to antibacterials/sanitization methods and causes the formation of a tonsillolith, referred to as SCP-XXXX-A, at the back of an infected individual’s throat. Despite being a type of bacteria, SCP-XXXX is not self-sustaining and must rely on an external source of nutrients. It is unknown how many individuals are currently infected with SCP-XXXX; however, the total is estimated to be around 7,000 people across the globe. Strangely, SCP-XXXX appears to be noncommunicable until the development of SCP-XXXX-A on the host, which is quite limiting in terms of its infectivity. SCP-XXXX is transmitted through bodily fluids, eating infected food, or drinking infected water.
SCP-XXXX-A is a tonsillolith that develops once a subject contracts SCP-XXXX. This tonsillolith breaks off into three separate segments over time: the largest of which remains in the back of the throat of infected individuals. Most subjects report SCP-XXXX-A three days after they contract SCP-XXXX and gradually report progressively worsening symptoms throughout the next few days. Some subjects refuse to willingly eat or drink once SCP-XXXX-A forms, and will continue to do so until they succumb to dehydration. SCP-XXXX-A is only to be removed postmortem for research purposes due to the incident involving Subject █████████ and Dr. █████████ which caused the quarantine and subsequent destruction of Bio-Site-█████.
Addendum #XXXX-1: The following is an attempt to generalize the stages through which subjects experience during the course of their infection from Stage 1 (initial infection) to death. Though it is not currently understood why, around 35% of subjects do not advance to Stages 4 and 5 of infection.
Addendum #XXXX-2: Subject D-194, who had their tonsils removed prior to test date, was purposefully contaminated with SCP-XXXX. SCP-XXXX-A formed regardless, but D-194’s tonsils regenerated during the process. This was observed to be excruciatingly painful due to D-194’s endless wailing. Several other attempts were made with near identical results; it was concluded that no further testing would be conducted on subjects who had undergone a tonsillectomy. Those who were subject to these trials are to be put on suicide watch and will be psychiatrically evaluated.
Addendum #XXXX-3: A trial vaccine dubbed [DATA EXPUNGED] was produced and then administered to Subjects D-248, D-297, and D-362. Subjects underwent evaluation every day for thirty days and none of them became physically ill. It is presumed that the subjects' mental health deteriorated immensely during the trials due to their actions mere days later. This incident has since prompted further investigation and is still currently underway.
Addendum #XXXX-4: Vaccine trials have ceased due to the most recent incident involving a civilian subject being mistaken for a Class D (and the subject’s subsequent gangrene infection from the aforementioned vaccination). Further safety measures have been taken into effect, separating Class D from regular citizens who were affected by SCP-XXXX. The future status of these vaccine trials is currently being debated by personnel on the research team responsible for the trials and Dr. ████████, head of anomalous bacterial research.






Per 


